Moreover, high expression of MYO1B, MYO5A, and MYO10 was shown to associate with the unfavorable overall survival of HNSCC patients, while the prognostic value of MYO5C was not significant as well as the moderate ROC diagnostic value. The gene discussed is MYO5A; the disease is head and neck squamous cell carcinoma.